Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study
- PMID: 34807722
- DOI: 10.7326/M21-2981
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study
Abstract
Background: The incidence of pulmonary embolism has been increasing, but its case-fatality rate is decreasing, suggesting a lesser severity of illness. The clinical importance of patients with pulmonary embolism isolated to the subsegmental vessels is unknown.
Objective: To determine the rate of recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation.
Design: Multicenter prospective cohort study. (ClinicalTrials.gov: NCT01455818).
Setting: Eighteen sites between February 2011 and February 2021.
Patients: Patients with isolated subsegmental pulmonary embolism.
Intervention: At diagnosis, patients underwent bilateral lower-extremity venous ultrasonography, which was repeated 1 week later if results were negative. Patients without deep venous thrombosis did not receive anticoagulant therapy.
Measurements: The primary outcome was recurrent venous thromboembolism during the 90-day follow-up period.
Results: Recruitment was stopped prematurely because the predefined stopping rule was met after 292 of a projected 300 patients were enrolled. Of the 266 patients included in the primary analysis, the primary outcome occurred in 8 patients, for a cumulative incidence of 3.1% (95% CI, 1.6% to 6.1%) over the 90-day follow-up. The incidence of recurrent venous thromboembolism was 2.1% (CI, 0.8% to 5.5%) and 5.7% (CI, 2.2% to 14.4%) over the 90-day follow-up in patients with single and multiple isolated subsegmental pulmonary embolism, respectively. No patients had a fatal recurrent pulmonary embolism.
Limitation: The study was restricted to patients with low-risk subsegmental pulmonary embolism.
Conclusion: Overall, patients with subsegmental pulmonary embolism who did not have proximal deep venous thrombosis had a higher-than-expected rate of recurrent venous thromboembolism.
Primary funding source: Heart and Stroke Foundation of Canada and French Ministry of Health Programme Hospitalier de Recherche Clinique.
Comment in
-
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.Ann Intern Med. 2022 Apr;175(4):W43. doi: 10.7326/L22-0037. Ann Intern Med. 2022. PMID: 35436438 No abstract available.
-
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.Ann Intern Med. 2022 Apr;175(4):W43-W44. doi: 10.7326/L22-0038. Ann Intern Med. 2022. PMID: 35436439 No abstract available.
Similar articles
-
Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol.Health Technol Assess. 2024 Jun 26:1-17. doi: 10.3310/HRCW7937. Online ahead of print. Health Technol Assess. 2024. PMID: 38970429
-
Management of single subsegmental pulmonary embolism: a prospective observational study at North Shore and Waitakere Hospitals, Auckland.Intern Med J. 2023 Feb;53(2):216-220. doi: 10.1111/imj.15531. Epub 2022 Jul 16. Intern Med J. 2023. PMID: 34523216
-
Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism.Thromb Res. 2024 Jul;239:109037. doi: 10.1016/j.thromres.2024.109037. Epub 2024 May 17. Thromb Res. 2024. PMID: 38781706
-
The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism.Ann Intern Med. 1998 Dec 15;129(12):1044-9. doi: 10.7326/0003-4819-129-12-199812150-00009. Ann Intern Med. 1998. PMID: 9867760 Review.
-
Towards evidence-based emergency medicine:best BETs from the Manchester Royal Infirmary. BET 1: Do patients with a clinically suspected subsegmental pulmonary embolism need anticoagulation therapy?Emerg Med J. 2015 Sep;32(9):744-7. doi: 10.1136/emermed-2015-205210.1. Emerg Med J. 2015. PMID: 26293150 Review.
Cited by
-
How I treat acute venous thromboembolism in patients with brain tumors.Blood. 2024 Oct 24;144(17):1781-1790. doi: 10.1182/blood.2023023450. Blood. 2024. PMID: 39197077
-
The Incidence of Pulmonary Embolism in Hospitalized Non-ICU Patients with COVID-19 during the First Wave: A Multicenter Retrospective Cohort Study in the Netherlands.J Vasc Res. 2024;61(3):142-150. doi: 10.1159/000538312. Epub 2024 Apr 17. J Vasc Res. 2024. PMID: 38631294 Free PMC article.
-
The History of Diagnosing Venous Thromboembolism.Semin Thromb Hemost. 2024 Jul;50(5):739-750. doi: 10.1055/s-0044-1779484. Epub 2024 Feb 19. Semin Thromb Hemost. 2024. PMID: 38373722 Free PMC article. Review.
-
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion.Hamostaseologie. 2024 Jun;44(3):193-196. doi: 10.1055/a-2173-7712. Epub 2023 Oct 30. Hamostaseologie. 2024. PMID: 37903615 Free PMC article.
-
Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study.Lancet Reg Health Eur. 2023 Sep 28;34:100739. doi: 10.1016/j.lanepe.2023.100739. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37809052 Free PMC article.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous